Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company, reports the Associated Press.

The solution accelerates syringe selection through its comprehensive performance and regulatory data packages.

Increasing awareness of medication adherence and patient safety is accelerating adoption of packaging solutions with superior protection and usability.

The medical device industry is leveraging digital manufacturing to get prototypes and final product to market faster than ...